Spots Global Cancer Trial Database for A Study to Assess the Absolute Bioavailability of Oral Selumetinib in Healthy Male Volunteers.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Assess the Absolute Bioavailability of Oral Selumetinib in Healthy Male Volunteers.
Official Title: A Study to Assess the Absolute Bioavailability of a Single Oral Dose of Selumetinib With Respect to an Intravenous Microdose of [14C] Selumetinib in Healthy Male Volunteers
Study ID: NCT02238782
Conditions
Study Description
Brief Summary: To assess the absolute bioavailability of oral selumetinib in healthy male volunteers
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: Yes
Locations
Research Site, Nottingham, , United Kingdom
Contact Details
Name: Stuart Mair
Affiliation: Quotient Clinical Ltd
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
